Cogentix Medical

The Law Offices of Vincent Wong Notifies Investors of an Investigation into Cogentix Medical, Inc. in Connection with the Sale of the Company to LABORIE Medical Technologies

NEW YORK--(BUSINESS WIRE)--

The Law Offices of Vincent Wong are investigating the Board of Directors of Cogentix Medical, Inc. (“Cogentix” or the “Company”) (NASDAQCM:CGNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to LABORIE Medical Technologies. Under the terms of the deal, Cogentix stockholders will receive $3.85 in cash for each share of Cogentix they own.

The investigation concerns whether the Cogentix Board of Directors breached their fiduciary duties to Cogentix stockholders by failing to adequately shop the Company before entering into this transaction and whether LABORIE Medical Technologies is underpaying for Cogentix shares, thus unlawfully harming Cogentix stockholders.

If you own common stock in Cogentix and wish to obtain additional information, please contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or http://docs.wongesq.com/CGNT-Info-Request-Form-1859.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
20/03/2018

Underlying

Cogentix Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cogentix Medical

Free Trial
Cogentix Medica...

Cognyte Software Ltd: 2 directors

Two Directors at Cognyte Software Ltd sold 20,000 shares at 7.570USD. The significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

COGENTIX MEDICAL
06/29/24 June 29, 2024 1 EN
 PRESS RELEASE
Free
Cogentix Medica...

The Law Offices of Vincent Wong Reminds Investors of an Investigation ...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Cogentix Medical, Inc. (“Cogentix” or the “Company”) (NASDAQCM:CGNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to LABORIE Medical Technologies. Under the terms of the deal, Cogentix stockholders will receive $3.85 in cash for each share of Cogentix they own. The investigation concerns whether the Cogentix Board of Directors breached their fiduciary d...

April 9, 2018 1 EN
 PRESS RELEASE
Free
Cogentix Medica...

The Law Offices of Vincent Wong Notifies Investors of an Investigation...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Cogentix Medical, Inc. (“Cogentix” or the “Company”) (NASDAQCM:CGNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to LABORIE Medical Technologies. Under the terms of the deal, Cogentix stockholders will receive $3.85 in cash for each share of Cogentix they own. The investigation concerns whether the Cogentix Board of Directors breached their fiduciary d...

March 20, 2018 1 EN
 PRESS RELEASE
Free
Cogentix Medica...

INVESTOR ALERT: Brower Piven Commences an Investigation into the Propo...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cogentix Medical, Inc. (Nasdaq: CGNT) (“Cogentix” or the “Company”) relating to the proposed buyout of Cogentix by LABORIE Medical Technologies. Under the terms of the agreement, Cogentix shareholders are anticipated to receive $3.85 in cash for each share of Cogentix common stock ...

March 20, 2018 1 EN
 PRESS RELEASE
Free
Cogentix Medica...

COGENTIX MEDICAL, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie B...

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Cogentix Medical, Inc. (“Cogentix”) (NASDAQ: CGNT) concerning the sale to LABORIE Medical Technologies, Inc. Under the terms of the agreement, Cogentix shareholders will only receive $3.85 in cash for each share owned, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $5.00 per share. If you are a...

March 19, 2018 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch